A mum has set up a charity in honour of her daughter who has an extremely rare brain disorder. Caryn de Nocker was devastated after finding out nine-year-old Hermione will be left with dementia, ...
The Parkinson’s Foundation estimates that 15,000 people here in Wisconsin have Parkinson’s disease, and that number is only ...
Parkinson’s patients and their caregivers attended the first “Parkinson’s Today: An Educational Symposium” in Palm Desert on Saturday. PRO or Parkinson’s Resource Organization teamed up with The ...
Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease. Students, in coordination with ...
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
5d
GlobalData on MSNAstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trialResearchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...
Sharon Osbourne has opened up about the declining health of her husband Ozzy Osbourne amid his ongoing battle with ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results